The most recent coverage is at the top; scroll down the page for prior coverage.
25 November 2021: updated coverage note for Hemogenyx Pharmaceuticals
SP Angel Hemogenyx Pharmaceuticals Update Note 20211125
23 July 2020: updated coverage note for Hemogenyx Pharmaceuticals
SP Angel Hemogenyx Update Note 20200723
29 August 2019: Initiation of coverage note for Hemogenyx Pharmaceuticals
SP Angel Hemogenyx Pharmaceuticals Initiation of Coverage Note 20190829 
Access to SP Angel’s research via this web site is subject to the following terms and conditions. SP Angel (‘SPA’) does not deal with individual or private investors (save in connection with corporate finance business). SPA’s research is thus not prepared for private investors and does not take into account any particular investor’s or class of investors’ investment objectives. You are therefore not being granted access to SPA research in your capacity as an investor or SPA client or potential investor or client. You understand that SPA is not offering you any financial service. Members of SPA’s Research department are not permitted to interact with private investors and you should not attempt to contact them.